NISA Investment Advisors »

Actuate Therapeutics shares owned by NISA Investment Advisors

Quarter-by-quarter ownership of Actuate Therapeutics (ACTU) shares owned by NISA Investment Advisors from 13F filings

Historical chart of NISA Investment Advisors investment in Actuate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Actuate Therapeutics held by NISA Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Actuate Therapeutics by NISA Investment Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $237 87 2.74

More positions owned by NISA Investment Advisors

iShares S&P 500 Index (IVV)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Inc Class A cs (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Inc Class C cs (GOOG)
Facebook Inc cl a (META)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Exxon Mobil Corporation (XOM)
Johnson & Johnson (JNJ)
Wal-Mart Stores (WMT)

View all positions for NISA Investment Advisors

Top funds holding Actuate Therapeutics

BIOS Capital Management
Voss Capital
Vanguard Group
BlackRock
Vanguard Capital Management
Geode Capital Management
Connective Capital Management
Northern Trust
Texas Capital Bank Wealth Management Services
Vanguard Fiduciary Trust
State Street Corporation
Vanguard Portfolio Management
ABS Direct Equity Fund
Rock Creek Group
Deutsche Bank Aktiengesellschaft

View all funds holding Actuate Therapeutics